CGH
TBI

Crossmark Global Holdings’s Trueblue TBI Stock Holding History

Crossmark Global Holdings’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,928
Closed -$183K – 1354
2023
Q4 		$183K Sell
11,928
-120
-1% -$1.68K ﹤0.01% 1262
2023
Q3 		$183K Hold
12,048
– – ﹤0.01% 1214
2023
Q2 		$180K Sell
12,048
-68
-0.6% -$1.15K ﹤0.01% 1261
2023
Q1 		$215K Buy
12,116
+622
+5% +$11.6K 0.01% 1196
2022
Q4 		$225K Buy
11,494
+664
+6% +$13.5K 0.01% 1146
2022
Q3 		$207K Sell
10,830
-100
-0.9% -$2.02K 0.01% 1160
2022
Q2 		$195K Sell
10,930
-240
-2% -$5.63K 0.01% 1221
2022
Q1 		$323K Sell
11,170
-80
-0.7% -$2.2K 0.01% 1107
2021
Q4 		$311K Buy
+11,250
New +$318K 0.01% 1132
2021
Q3 		– Sell
-7,250
Closed -$204K – 1434
2021
Q2 		$204K Sell
7,250
-1,950
-21% -$51.9K ﹤0.01% 1371
2021
Q1 		$203K Buy
+9,200
New +$189K 0.01% 1365
2020
Q4 		– Sell
-14,260
Closed -$221K – 1429
2020
Q3 		$221K Hold
14,260
– – 0.01% 1182
2020
Q2 		$218K Buy
14,260
+3,280
+30% +$48.7K 0.01% 1197
2020
Q1 		$140K Hold
10,980
– – 0.01% 1128
2019
Q4 		$264K Hold
10,980
– – 0.01% 1189
2019
Q3 		$232K Sell
10,980
-150
-1% -$3.1K 0.01% 1192
2019
Q2 		$246K Buy
11,130
+70
+0.6% +$1.62K 0.01% 1188
2019
Q1 		$261K Sell
11,060
-40
-0.4% -$934 0.01% 1183
2018
Q4 		$247K Sell
11,100
-2,420
-18% -$58K 0.01% 1182
2018
Q3 		$352K Buy
13,520
+120
+0.9% +$3.33K 0.01% 1205
2018
Q2 		$361K Sell
13,400
-150
-1% -$3.97K 0.01% 1170
2018
Q1 		$351K Sell
13,550
-1,880
-12% -$51.4K 0.01% 1159
2017
Q4 		$424K Sell
15,430
-830
-5% -$22K 0.01% 1118
2017
Q3 		$365K Buy
+16,260
New +$368K 0.01% 1175
2016
Q3 		$365K Buy
+16,260
New +$355K 0.01% 1175

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Crossmark Global Holdings's TBI Position: Q1 2024 in Review

Crossmark Global Holdings sold out of Trueblue (TBI) in Q1 2024, closing a stake of 11,928 shares — an estimated $183K sold.

Crossmark Global Holdings first reported a position in TBI in Q3 2016 and held it in 25 quarters. The position peaked at $424K in Q4 2017. 137 funds tracked by Wall St. Rank hold TBI as of Q1 2024.

  • Crossmark Global Holdings reported no remaining Trueblue position as of Q1 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 11,928 Trueblue shares in Q1 2024, an estimated $183K.
  • Crossmark Global Holdings first reported a position in Trueblue in Q3 2016 and held it in 25 quarters.
  • Crossmark Global Holdings's Trueblue position peaked at $424K in Q4 2017.
  • 137 funds tracked by Wall St. Rank held Trueblue as of Q1 2024.

Based on Crossmark Global Holdings's 13F filing for Q1 2024, filed 13 May 2024.